Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine (Q41034813)
Jump to navigation
Jump to search
scientific article published on March 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine |
scientific article published on March 1998 |
Statements
1 reference
Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine (English)
1 reference
Clary A
1 reference
Larrue A
1 reference
Pourquier P
1 reference
Robert J
1 reference
1 March 1998
1 reference
March 1998
0 references
1 reference